Maraganore John insider trades
Maraganore John has filed 23 Form 4s with the SEC that we hold, for Beam Therapeutics Inc. (BEAM) (Director), Kymera Therapeutics, Inc. (KYMR) (Director), Alnylam Pharmaceuticals, INC. (ALNY) (Chief Executive Officer, Director) and Agios Pharmaceuticals, INC. (AGIO) (Director), among 8 companies in all. Across all of them we count 0 purchases worth $0 and 10 sales worth $12.6M reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a sale of 23,336 shares of Alnylam Pharmaceuticals, INC. worth $4.7M, dated 2021-08-13. The first filing on our record is dated 2021-08-16 and the latest 2026-07-06.
Beam Therapeutics Inc. (BEAM)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Kymera Therapeutics, Inc. (KYMR)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Alnylam Pharmaceuticals, INC. (ALNY)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2021-08-13 | S, sale reported on Form 4 | 2,441 | $483.4K | 2021-08-16 |
| 2021-08-13 | S, sale reported on Form 4 | 4,160 | $827.5K | 2021-08-16 |
| 2021-08-13 | S, sale reported on Form 4 | 3,828 | $768.8K | 2021-08-16 |
| 2021-08-13 | S, sale reported on Form 4 | 214 | $43.1K | 2021-08-16 |
| 2021-08-13 | S, sale reported on Form 4 | 23,336 | $4.7M | 2021-08-16 |
| 2021-11-12 | S, sale reported on Form 4 | 10,365 | $1.8M | 2021-11-12 |
| 2021-11-12 | S, sale reported on Form 4 | 7,742 | $1.3M | 2021-11-12 |
| 2021-11-12 | S, sale reported on Form 4 | 14,518 | $2.5M | 2021-11-12 |
| 2021-11-12 | S, sale reported on Form 4 | 683 | $118.3K | 2021-11-12 |
| 2021-11-12 | S, sale reported on Form 4 | 670 | $116.8K | 2021-11-12 |
Agios Pharmaceuticals, INC. (AGIO)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Prokidney Corp. (PROK)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Rapport Therapeutics, Inc. (RAPP)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Hemab Therapeutics Holdings, Inc. (COAG)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Takeda Pharmaceutical Co LTD (TAK)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1180432) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms